Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).
NCT04142723 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2019-10-29
Summary
The primary objective of this study is to determine the prevalence of AH in addition to its clinical characteristics and in-hospital mortality of patients that are hospitalized for AH in different hospitals across Latin American countries This study is carried out in different health centers throughout America, with all the countries belonging to the Latin American Association for the study of liver diseases (ALEH) more Canada and United States This would allow us to better understand the epidemiology of AH in our region and thus implement prevention measures with more solid data. Importantly, this would allow us to optimize therapeutic measures
Conditions
- Hepatitis, Alcoholic
Interventions
- BIOLOGICAL
-
blood withdraw
venous blood sampling
Sponsors & Collaborators
-
ALEH
collaborator UNKNOWN -
Hospital Nacional Hipolito
collaborator UNKNOWN -
Hospital Goyoneche Arequipa
collaborator UNKNOWN -
Hospital Nacional Edgardo Rebagliati Martins
collaborator OTHER -
HBCASE
collaborator UNKNOWN -
Hospital Regional Honorio Delgado Arequipa Peru
collaborator UNKNOWN -
Hospital Nacional Daniel Alcides Carrión - Callao
collaborator UNKNOWN -
Instituto de Gastroenterología
collaborator UNKNOWN -
Hospital Docente Clinico Quirurgico:Manuel Piti Fajardo
collaborator UNKNOWN -
Hospital de Clínicas D. N. Avellaneda
collaborator UNKNOWN -
Hospital Padilla. Tucuman
collaborator UNKNOWN -
Hospital Pablo Soria. Jujuy
collaborator UNKNOWN -
FUNDACIÓN SAYANI
collaborator UNKNOWN -
Hospital Italiano Buenos Aires
collaborator UNKNOWN -
Rosario
collaborator UNKNOWN -
Hospital de Gastroenterología Dr Carlos Bonorino Udaondo
collaborator UNKNOWN -
Hospital Austral de Buenos Aires
collaborator UNKNOWN -
Francisco Alfonso Solís Galindo
collaborator UNKNOWN -
Centro de Investigación en Enfermedades Hepáticas y Gastroenterología
collaborator UNKNOWN -
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
collaborator OTHER -
Hospital General de Mexico
collaborator OTHER_GOV -
Hospital Eugenio Espejo
collaborator UNKNOWN -
Hospital de Especialidades de las FF.AA Quito
collaborator UNKNOWN -
Hospital Carlos Andrade Marín
collaborator UNKNOWN -
Hospital General San Juan de Dios
collaborator UNKNOWN -
Hospital Roosevelt
collaborator UNKNOWN -
Hospital San Vicente Fundación Medellín
collaborator UNKNOWN -
Clinica Universitaria Colombia
collaborator UNKNOWN -
Hospital San Vicente Fundación - Rionegro
collaborator UNKNOWN -
Fundacion Cardioinfantil
collaborator UNKNOWN -
Hospital Pablo Tobon Uribe. Univ. De Antioquia
collaborator UNKNOWN -
Fundação Hospital Adriano Jorge
collaborator UNKNOWN -
Hospital do Rocio
collaborator UNKNOWN -
Hospital das Clinacas Riberao Preto
collaborator UNKNOWN -
Universidade Estadual Paulista (UNESP) - Botucatu/São Paulo
collaborator UNKNOWN -
FUNDHACRE- Serviço de Assistência Especializada- Acre
collaborator UNKNOWN -
Hospital Getúlio Vargas - Teresina/Piauí
collaborator UNKNOWN -
Hospital do Servidor Público Estadual - São Paulo/São Paulo
collaborator UNKNOWN -
Hospital Federal de Bonsucesso - Rio de Janeiro/Rio de Janeiro
collaborator UNKNOWN -
CHP/ Cl Davila / HCUH
collaborator UNKNOWN -
Hospital San Juan de Dios
collaborator UNKNOWN -
Hospital Sotero Del Rio
collaborator UNKNOWN -
Hospital San Borja-Arriaran
collaborator OTHER -
University of Chile
collaborator OTHER -
Hospital Clinico Universidad Catolica
collaborator UNKNOWN -
Hospital de Concepcion
collaborator UNKNOWN -
Hospital Escuela
collaborator UNKNOWN -
Pontificia Universidad Catolica de Chile
lead OTHER
Principal Investigators
-
juan pablo p arab, md · Pontificia Universidad Catolica de Chile
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-20
- Primary Completion
- 2022-06-20
- Completion
- 2022-06-20
Countries
- Chile
Study Locations
More Related Trials
-
Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function
NCT01438970 ·Status: UNKNOWN ·Phase: PHASE2
-
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
NCT02172898 ·Status: COMPLETED
-
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
NCT03056612 ·Status: COMPLETED
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921 ·Status: RECRUITING
-
ALFApump System Post Marketing Surveillance Registry
NCT01532427 ·Status: COMPLETED
-
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites
NCT02400164 ·Status: COMPLETED ·Phase: NA
-
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
NCT05294744 ·Status: RECRUITING ·Phase: NA
-
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
NCT03281265 ·Status: COMPLETED
-
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
NCT04234139 ·Status: ENROLLING_BY_INVITATION
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation
NCT04530760 ·Status: RECRUITING
-
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury
NCT03204591 ·Status: UNKNOWN
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
NCT07087041 ·Status: NOT_YET_RECRUITING
-
Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery
NCT01435421 ·Status: UNKNOWN
-
Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP
NCT07262515 ·Status: RECRUITING
-
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453 ·Status: UNKNOWN
-
Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis
NCT05413083 ·Status: ACTIVE_NOT_RECRUITING
-
Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure
NCT02737345 ·Status: COMPLETED
-
Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites
NCT03451292 ·Status: COMPLETED ·Phase: PHASE3
-
Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.
NCT05883891 ·Status: COMPLETED
-
Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
NCT02158182 ·Status: COMPLETED ·Phase: PHASE4
-
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
NCT01471028 ·Status: COMPLETED ·Phase: PHASE3
-
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
NCT02401490 ·Status: UNKNOWN ·Phase: PHASE4
-
Dynamic Liver Tests in Liver Disease
NCT02782247 ·Status: COMPLETED